Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Not yet recruiting 2Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lung Neoplasms 4Multiple Pulmonary Nodules 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Solitary Pulmonary Nodule 1Smoking Cessation 1Small Cell Lung Carcinoma 1Recurrence 1Melanoma 1Lymphoma, Follicular 1Lung Diseases 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1Glioma 1Depressive Disorder, Major 1Breast Neoplasms 1Breast Neoplasm Female 1Bone Neoplasms 1Barrett Esophagus 1Adenocarcinoma of Lung 1Adenocarcinoma 1

Interventions

Carboplatin 341Paclitaxel 262Cisplatin 233Pemetrexed 226Docetaxel 206Erlotinib Hydrochloride 193Gemcitabine 178pembrolizumab 137Bevacizumab 121Radiotherapy 118Nivolumab 84Gefitinib 73Vinorelbine 64Cetuximab 58atezolizumab 47Afatinib 46durvalumab 44osimertinib 41Radiosurgery 35Ipilimumab 34Drug Therapy 32Taxes 30Albumin-Bound Paclitaxel 29130-nm albumin-bound paclitaxel 29Surgical Procedures, Operative 28Etoposide 25Irinotecan 24Sorafenib 21Cyclophosphamide 20Radiation 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Carcinoma, Non-Small-Cell Lung × Diagnostic Imaging × Clear all
NCT03704870 2020-05-01

Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection

University Health Network, Toronto

Phase 2 Completed
50 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms

NCT00047385 2014-05-20

NLST

National Cancer Institute (NCI)

Phase 3 Completed
53,454 enrolled 15 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡